Cancer Research  09 AM Call for Abstracts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 34, 1738-1742, July 1, 1974]
© 1974 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hiramoto, R. N.
Right arrow Articles by Ghanta, V. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hiramoto, R. N.
Right arrow Articles by Ghanta, V. K.

Chemotherapy and Rate of Kill of Tumor Cells in a Mouse Plasmacytoma1

Raymond N. Hiramoto and Vithal K. Ghanta

The Department of Microbiology, University of Alabama Medical Center, Birmingham, Alabama 35294

An experimental model has been devised to measure within the body of a single animal various parameters required for rational cancer chemotherapy. The growth and regression of tumor cells has been tested using cyclophosphamide as an effective chemotherapeutic agent. It was found that the tumor grew at an average rate of 2%/hr and could be regressed about 2%/hr. The rates of growth between s.c. and i.v. implants were slightly different as were their rates of regression under cyclophosphamide therapy (whether this depends on initial size of the tumor at the time cyclophosphamide was given has not been investigated). The model can be used to predict the starting populations of a tumor inoculum (t0) as well as the time it will take to destroy the last single viable tumor cell in an individual mouse.

1 This investigation was supported by Grant GB 13804 from the National Science Foundation and American Cancer IN-66L.

Received 12/12/73. Accepted 4/ 5/74.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1974 by the American Association for Cancer Research.